Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Warfarin and Polypeptides

supplement:

Polypeptides

Research Papers that Mention the Interaction

Specifically, variants in the genes that encode an enzyme responsible for the metabolism of warfarin [cytochrome P450, family 2, subfamily C, polypeptide 9 ( CYP2C9 )3] and the molecular target of warfarin [vitamin K epoxide reductase complex, subunit 1 ( VKORC1 )] influence warfarin dosing.
Clinical chemistry  •  2014  |  View Paper
Genetic variations in the cytochrome P450, family 2, subfamily C, polypeptide 9 (CYP2C9), vitamin K epoxide reductase complex, subunit 1 (VKORC1), and gamma-glutamyl carboxylase (GGCX) genes have been shown to contribute to impaired metabolism of warfarin.
Clinical chemistry  •  2009  |  View Paper
BACKGROUND Polymorphisms of the CYP2C9 (cytochrome P450, family 2, subfamily C, polypeptide 9) gene (CYP2C9*2, CYP2C9*3) and the VKORC1 (vitamin K epoxide reductase complex, subunit 1) gene (-1639G>A) greatly impact the maintenance dose for the drug warfarin.
Clinical chemistry  •  2009  |  View Paper